⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
SPRY ALERT: Securities Fraud Class Action Launched Against ARS Pharmaceuticals, Inc. - October 5, 2026 Deadline
accessnewswire.com
SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
SPRY
SPRY SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. (SPRY) Investors - Lead Plaintiff Deadline on October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Investor Alert: Deadline Approaching to Join ARS Pharmaceuticals, Inc. (SPRY) Class Action - Contact Levi & Korsinsky
accessnewswire.com
SPRY
ROSEN, A LEADING NATIONAL FIRM, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Kaplan Fox Notifies Investors of ARS Pharmaceuticals Inc. (SPRY) of a Securities Fraud Class Action Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Class Action Lawsuit Filed: ARS Pharmaceuticals, Inc. (SPRY) - Join by October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY